(Ivanhoe Newswire) -- A breast cancer patient's genetic makeup could
influence the way she reacts to treatment options. This is the conclusion of a
new study conducted by researchers at The University of Texas M.D. Anderson
Cancer Center.
Researchers discovered women whose cells harbor harmful mutations in the BRCA
genes are likely to view preventive mastectomy as the best way to reduce their
risk and fears of developing breast cancer, despite other, less drastic
treatment options.
This research could help physicians and other clinicians as they discuss test
results with women who undergo BRCA gene testing.
"Health care providers and genetic counselors must take this into account when
assessing a woman's needs at the time of genetic testing and results
disclosure," study authors wrote.
SOURCE: Cancer, April 2009
